These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7957889)

  • 1. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro.
    Chao CC; Shieh TC; Huang H
    FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells.
    Chao CC
    Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
    Chao CC
    Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair.
    Chao CC
    Eur J Pharmacol; 1996 Jun; 305(1-3):213-22. PubMed ID: 8813556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
    Sundquist WI; Lippard SJ; Stollar BD
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.
    Mello JA; Lippard SJ; Essigmann JM
    Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.
    Yaneva J; Leuba SH; van Holde K; Zlatanova J
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
    Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM
    Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
    Liedert B; Pluim D; Schellens J; Thomale J
    Nucleic Acids Res; 2006 Mar; 34(6):e47. PubMed ID: 16571898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by arsenite of anticancer drug cis-diamminedichloroplatinum(II) induced DNA repair and drug resistance in HeLa cells.
    Chao CC
    Environ Toxicol Pharmacol; 1996 May; 1(3):199-205. PubMed ID: 21781682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
    Malina J; Kasparkova J; Natile G; Brabec V
    Chem Biol; 2002 May; 9(5):629-38. PubMed ID: 12031669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
    Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
    Tilby MJ; Johnson C; Knox RJ; Cordell J; Roberts JJ; Dean CJ
    Cancer Res; 1991 Jan; 51(1):123-9. PubMed ID: 1703029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
    Heiger-Bernays WJ; Essigmann JM; Lippard SJ
    Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II).
    Clugston CK; McLaughlin K; Kenny MK; Brown R
    Cancer Res; 1992 Nov; 52(22):6375-9. PubMed ID: 1423284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.
    Mello JA; Acharya S; Fishel R; Essigmann JM
    Chem Biol; 1996 Jul; 3(7):579-89. PubMed ID: 8807890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent alterations in the early stage of excision repair of UV-induced DNA damages in a HeLa mutant cell line that is resistant to genotoxic stresses.
    Chao CC; Huang SL
    Mutat Res; 1993 Sep; 303(1):19-27. PubMed ID: 7690902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
    Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.
    Calsou P; Frit P; Salles B
    Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
    Kaspárková J; Brabec V
    Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.